RNTX
RNTX clinical trials: Rein Therapeutics, Inc.
Every trial on ClinicalTrials.gov where Rein Therapeutics, Inc. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 4
- Trials linked
- 4
- As lead sponsor
- 0
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
RNTX on the catalyst calendar · RNTX registry changes
| Primary completion | Trial | Company and role | Phase | Status | Enrollment | Interventions | Completion |
|---|---|---|---|---|---|---|---|
| Sep 30, 2027Sponsor estimate | NCT06968845A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary FibrosisRein Therapeutics · Idiopathic Pulmonary Fibrosis (IPF) | RNTXLead | Phase 2 | Recruiting | Locked | Locked | Locked |
| Sep 25, 2024Actual | NCT05954988A Study to Evaluate LTI-03 in Newly Diagnosed Idiopathic Pulmonary Fibrosis (IPF) PatientsRein Therapeutics · Idiopathic Pulmonary Fibrosis | RNTXLead | Phase 1 | Completed | Locked | Locked | Locked |
| Mar 31, 2022Actual | NCT04159831A Study to Evaluate LTI-01 in Patients With Infected, Non-draining Pleural EffusionsRein Therapeutics · Pleural Effusion | RNTXLead | Phase 2 | Completed | Locked | Locked | Locked |
| Dec 23, 2021Actual | NCT04233814Safety, Tolerability and Pharmacokinetic Study of LTI-03 in Healthy Adult SubjectsRein Therapeutics · Idiopathic Pulmonary Fibrosis | RNTXLead | Phase 1 | Completed | Locked | Locked | Locked |
- Primary completion Sep 30, 2027Sponsor estimatePhase 2NCT06968845A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary FibrosisRein Therapeutics · Idiopathic Pulmonary Fibrosis (IPF)RecruitingRNTXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 25, 2024ActualPhase 1NCT05954988A Study to Evaluate LTI-03 in Newly Diagnosed Idiopathic Pulmonary Fibrosis (IPF) PatientsRein Therapeutics · Idiopathic Pulmonary FibrosisCompletedRNTXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 31, 2022ActualPhase 2NCT04159831A Study to Evaluate LTI-01 in Patients With Infected, Non-draining Pleural EffusionsRein Therapeutics · Pleural EffusionCompletedRNTXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 23, 2021ActualPhase 1NCT04233814Safety, Tolerability and Pharmacokinetic Study of LTI-03 in Healthy Adult SubjectsRein Therapeutics · Idiopathic Pulmonary FibrosisCompletedRNTXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 4 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner